Ling L - Search Results

1

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.

Zhou M, Learned RM, Rossi SJ, DePaoli AM, Tian H, Ling L. Zhou M, et al. Among authors: ling l. Hepatology. 2016 Mar;63(3):914-29. doi: 10.1002/hep.28257. Epub 2015 Nov 30. Hepatology. 2016. PMID: 26418580 Free PMC article.

2

Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors.

He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L. He W, et al. Among authors: ling l. Nature. 2004 May 13;429(6988):188-93. doi: 10.1038/nature02488. Nature. 2004. PMID: 15141213

3

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.

Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L. Wang J, et al. Among authors: ling l. J Biol Chem. 2006 Aug 4;281(31):22021-22028. doi: 10.1074/jbc.M603503200. Epub 2006 Jun 5. J Biol Chem. 2006. PMID: 16754668 Free article.

4

Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.

Wang J, Wu X, Simonavicius N, Tian H, Ling L. Wang J, et al. Among authors: ling l. J Biol Chem. 2006 Nov 10;281(45):34457-64. doi: 10.1074/jbc.M608019200. Epub 2006 Sep 11. J Biol Chem. 2006. PMID: 16966319 Free article.

5

G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response.

Gardner J, Wu S, Ling L, Danao J, Li Y, Yeh WC, Tian H, Baribault H. Gardner J, et al. Among authors: ling l. Biochem Biophys Res Commun. 2012 Feb 3;418(1):1-5. doi: 10.1016/j.bbrc.2011.11.117. Epub 2011 Dec 1. Biochem Biophys Res Commun. 2012. PMID: 22155242

6

Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.

Zhou M, Wang X, Phung V, Lindhout DA, Mondal K, Hsu JY, Yang H, Humphrey M, Ding X, Arora T, Learned RM, DePaoli AM, Tian H, Ling L. Zhou M, et al. Among authors: ling l. Cancer Res. 2014 Jun 15;74(12):3306-16. doi: 10.1158/0008-5472.CAN-14-0208. Epub 2014 Apr 11. Cancer Res. 2014. PMID: 24728076

7

A nontumorigenic variant of FGF19 treats cholestatic liver diseases.

Luo J, Ko B, Elliott M, Zhou M, Lindhout DA, Phung V, To C, Learned RM, Tian H, DePaoli AM, Ling L. Luo J, et al. Among authors: ling l. Sci Transl Med. 2014 Jul 30;6(247):247ra100. doi: 10.1126/scitranslmed.3009098. Sci Transl Med. 2014. PMID: 25080475 Clinical Trial.

8

Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.

Zhou M, Luo J, Chen M, Yang H, Learned RM, DePaoli AM, Tian H, Ling L. Zhou M, et al. Among authors: ling l. J Hepatol. 2017 Jun;66(6):1182-1192. doi: 10.1016/j.jhep.2017.01.027. Epub 2017 Feb 9. J Hepatol. 2017. PMID: 28189755 Free article.

9

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

Zhou M, Yang H, Learned RM, Tian H, Ling L. Zhou M, et al. Among authors: ling l. Nat Commun. 2017 May 16;8:15433. doi: 10.1038/ncomms15433. Nat Commun. 2017. PMID: 28508871 Free PMC article.

10

Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.

Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Hartmann P, et al. Among authors: ling l. Hepatology. 2018 Jun;67(6):2150-2166. doi: 10.1002/hep.29676. Epub 2018 Apr 16. Hepatology. 2018. PMID: 29159825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,353 results

Search Page